Author: masuuglobal
What Is Regulatory Labeling Change Management?
What Is Regulatory Labeling Change Management? Regulatory labeling change management is the structured process of identifying, assessing, implementing, documenting, and tracking changes to the approved labeling of a pharmaceutical or medical product.
Regulatory Affairs Consultant: Your Partner in Global Regulatory Compliance
Regulatory Affairs Consultant: Your Partner in Global Regulatory Compliance A Regulatory Affairs Consultant plays a vital role in helping pharmaceutical, biotechnology, medical device, and healthcare companies navigate complex regulatory requirements.
Environmental Risk Assessment (ERA) Studies at OECD Labs
Environmental Risk Assessment (ERA) Studies at OECD Labs Environmental Risk Assessment (ERA) Studies at OECD Labs play a vital role in evaluating the potential impact of chemicals, pharmaceuticals, pesticides, and other substances on the environment.
What Is Environmental Risk Assessment (ERA) Phase II Tier B?
What Is Environmental Risk Assessment (ERA) Phase II Tier B? Environmental Risk Assessment (ERA) Phase II Tier B is a more detailed environmental investigation undertaken when the findings from an earlier assessment indicate that further evaluation is required.
What Is Environmental Risk Assessment (ERA) Phase II Tier A?
What Is Environmental Risk Assessment (ERA) Phase II Tier A? Environmental Risk Assessment (ERA) Phase II Tier A is the next stage in evaluating the environmental situation after a Phase I assessment has confirmed that there are environmental hazards that require further evaluation.
What Is Environmental Risk Assessment (ERA) Phase I?
What Is Environmental Risk Assessment (ERA) Phase I? The Environmental Risk Assessment (ERA) Phase I is regarded as the earliest environmental due diligence procedure. Its purpose is the analysis of environmental issues related to property, a facility, or a project.
FDA Updates Forms FDA 1571 and FDA 356h: Key Changes
FDA Updates Forms FDA 1571 and FDA 356h: Key Changes FDA has released updated versions of Form FDA 1571 (05/2026) and Form FDA 356h (05/2026) to support PDUFA VII requirements and improve data quality and usability.
What Is Regulatory Submission Planning?
What Is Regulatory Submission Planning? Regulatory Submission Planning is a process that allows the pharmaceutical, biotechnology, and medical devices sector to better organize and manage all the activities related to regulatory submissions.
What Is Multi-Region Drug Registration?
What Is Multi-Region Drug Registration? Multi-Region Drug Registration refers to the process of getting approval from the regulatory body for the marketing of the medical drug in multiple locations.
What Is Lifecycle Regulatory Strategy?
What Is Lifecycle Regulatory Strategy? The Lifecycle Regulatory Strategy refers to a systematic method of dealing with the regulatory obligations of a given pharmaceutical product as the regulatory needs arise over the product lifecycle.